Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01017
  • NSEID: AHCL
  • BSEID: 544497
INR
133.99
-3.9 (-2.83%)
BSENSE

Jan 19

BSE+NSE Vol: 63.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

63.59 k (-34.44%) Volume

Shareholding (Dec 2025)

FII

0.23%

Held by 4 FIIs

DII

4.40%

Held by 1 DIIs

Promoter

52.68%

Why is Anlon Healthcare falling/rising?

19-Jan-2026

As of 18-Jan, Anlon Healthcare Ltd's stock price is at 136.75, unchanged from the previous session, and has declined 4.60% over the past week. The stock is underperforming relative to the benchmark Sensex and is experiencing downward pressure due to recent price declines and reduced investor participation.

As of 18-Jan, Anlon Healthcare Ltd's stock price is currently at 136.75, with no change from the previous trading session. Over the past week, the stock has experienced a decline of 4.60%, while it has fallen by 2.22% over the past month and 9.65% year-to-date. In contrast, the benchmark Sensex has shown a minimal decline of only 0.01% for the week and a 1.31% decline for the month, indicating that Anlon Healthcare is underperforming relative to the broader market.<BR><BR>Despite today's performance, where the stock outperformed its sector by 1.11%, the overall trend suggests a lack of positive momentum. The stock is currently trading above its 100-day and 200-day moving averages, but it is below its 5-day, 20-day, and 50-day moving averages, which may indicate short-term weakness. Additionally, there has been a significant drop in investor participation, with delivery volume on January 14 falling by 64.58% compared to the 5-day average. This decline in trading activity could further contribute to the stock's downward pressure.<BR><BR>Overall, the combination of recent price declines, underperformance against the benchmark, and reduced investor participation suggests that Anlon Healthcare's stock is currently facing downward pressure.

View full answer

Which are the latest news on Anlon Healthcare?

19-Jan-2026
No latest news for Anlon Healthcare found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 712 Cr (Micro Cap)

stock-summary
P/E

35.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.07

stock-summary
Return on Equity

9.57%

stock-summary
Price to Book

3.39

Revenue and Profits:
Net Sales:
52 Cr
(Quarterly Results - Sep 2025)
Net Profit:
9 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.53%
0%
5.53%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
8.18
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
23.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.72%
ROCE (avg)
9.07%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
35
Industry P/E
33
Price to Book Value
3.32
EV to EBIT
23.83
EV to EBITDA
22.52
EV to Capital Employed
3.17
EV to Sales
6.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.30%
ROE (Latest)
9.57%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (0.23%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (0.075%)

Individual Investors Holdings

23.58%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 56.76% vs 37.77% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 162.54% vs 37.07% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.20",
          "val2": "33.30",
          "chgp": "56.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.73",
          "val2": "6.24",
          "chgp": "120.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.87",
          "val2": "0.82",
          "chgp": "6.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.32",
          "val2": "3.55",
          "chgp": "162.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.30%",
          "val2": "18.74%",
          "chgp": "7.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "95.30",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.69",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "2.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.91",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.71%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.21",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.72",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.52",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.78%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
52.20
33.30
56.76%
Operating Profit (PBDIT) excl Other Income
13.73
6.24
120.03%
Interest
0.87
0.82
6.10%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.32
3.55
162.54%
Operating Profit Margin (Excl OI)
26.30%
18.74%
7.56%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 56.76% vs 37.77% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 162.54% vs 37.07% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
85.50
62.00
37.90%
Operating Profit (PBDIT) excl Other Income
19.98
14.45
38.27%
Interest
1.68
1.91
-12.04%
Exceptional Items
0.00
0.00
Standalone Net Profit
12.86
6.36
102.20%
Operating Profit Margin (Excl OI)
23.37%
23.31%
0.06%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Jun'25stock-summary

Jun'25
Change(%)
Net Sales
95.30
NA
NA
Operating Profit (PBDIT) excl Other Income
20.69
NA
NA
Interest
2.73
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
9.91
NA
NA
Operating Profit Margin (Excl OI)
21.71%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
120.29
NA
NA
Operating Profit (PBDIT) excl Other Income
32.21
NA
NA
Interest
3.72
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
20.52
NA
NA
Operating Profit Margin (Excl OI)
26.78%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Anlon Healthcare Ltd stock-summary
stock-summary
Anlon Healthcare Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available